The dosimetric impact of deep learning-based auto-segmentation of organs at risk on nasopharyngeal and rectal cancer

To investigate the dosimetric impact of deep learning-based auto-segmentation of organs at risk (OARs) on nasopharyngeal and rectal cancer. Twenty patients, including ten nasopharyngeal carcinoma (NPC) patients and ten rectal cancer patients, who received radiotherapy in our department were enrolled...

Full description

Saved in:
Bibliographic Details
Published inRadiation oncology (London, England) Vol. 16; no. 1; pp. 113 - 14
Main Authors Guo, Hongbo, Wang, Jiazhou, Xia, Xiang, Zhong, Yang, Peng, Jiayuan, Zhang, Zhen, Hu, Weigang
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 23.06.2021
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract To investigate the dosimetric impact of deep learning-based auto-segmentation of organs at risk (OARs) on nasopharyngeal and rectal cancer. Twenty patients, including ten nasopharyngeal carcinoma (NPC) patients and ten rectal cancer patients, who received radiotherapy in our department were enrolled in this study. Two deep learning-based auto-segmentation systems, including an in-house developed system (FD) and a commercial product (UIH), were used to generate two auto-segmented OARs sets (OAR_FD and OAR_UIH). Treatment plans based on auto-segmented OARs and following our clinical requirements were generated for each patient on each OARs sets (Plan_FD and Plan_UIH). Geometric metrics (Hausdorff distance (HD), mean distance to agreement (MDA), the Dice similarity coefficient (DICE) and the Jaccard index) were calculated for geometric evaluation. The dosimetric impact was evaluated by comparing Plan_FD and Plan_UIH to original clinically approved plans (Plan_Manual) with dose-volume metrics and 3D gamma analysis. Spearman's correlation analysis was performed to investigate the correlation between dosimetric difference and geometric metrics. FD and UIH could provide similar geometric performance in parotids, temporal lobes, lens, and eyes (DICE, p > 0.05). OAR_FD had better geometric performance in the optic nerves, oral cavity, larynx, and femoral heads (DICE, p < 0.05). OAR_UIH had better geometric performance in the bladder (DICE, p < 0.05). In dosimetric analysis, both Plan_FD and Plan_UIH had nonsignificant dosimetric differences compared to Plan_Manual for most PTV and OARs dose-volume metrics. The only significant dosimetric difference was the max dose of the left temporal lobe for Plan_FD vs. Plan_Manual (p = 0.05). Only one significant correlation was found between the mean dose of the femoral head and its HD index (R = 0.4, p = 0.01), there is no OARs showed strong correlation between its dosimetric difference and all of four geometric metrics. Deep learning-based OARs auto-segmentation for NPC and rectal cancer has a nonsignificant impact on most PTV and OARs dose-volume metrics. Correlations between the auto-segmentation geometric metric and dosimetric difference were not observed for most OARs.
AbstractList Abstract Purpose To investigate the dosimetric impact of deep learning-based auto-segmentation of organs at risk (OARs) on nasopharyngeal and rectal cancer. Methods and materials Twenty patients, including ten nasopharyngeal carcinoma (NPC) patients and ten rectal cancer patients, who received radiotherapy in our department were enrolled in this study. Two deep learning-based auto-segmentation systems, including an in-house developed system (FD) and a commercial product (UIH), were used to generate two auto-segmented OARs sets (OAR_FD and OAR_UIH). Treatment plans based on auto-segmented OARs and following our clinical requirements were generated for each patient on each OARs sets (Plan_FD and Plan_UIH). Geometric metrics (Hausdorff distance (HD), mean distance to agreement (MDA), the Dice similarity coefficient (DICE) and the Jaccard index) were calculated for geometric evaluation. The dosimetric impact was evaluated by comparing Plan_FD and Plan_UIH to original clinically approved plans (Plan_Manual) with dose-volume metrics and 3D gamma analysis. Spearman’s correlation analysis was performed to investigate the correlation between dosimetric difference and geometric metrics. Results FD and UIH could provide similar geometric performance in parotids, temporal lobes, lens, and eyes (DICE, p > 0.05). OAR_FD had better geometric performance in the optic nerves, oral cavity, larynx, and femoral heads (DICE, p < 0.05). OAR_UIH had better geometric performance in the bladder (DICE, p < 0.05). In dosimetric analysis, both Plan_FD and Plan_UIH had nonsignificant dosimetric differences compared to Plan_Manual for most PTV and OARs dose-volume metrics. The only significant dosimetric difference was the max dose of the left temporal lobe for Plan_FD vs. Plan_Manual (p = 0.05). Only one significant correlation was found between the mean dose of the femoral head and its HD index (R = 0.4, p = 0.01), there is no OARs showed strong correlation between its dosimetric difference and all of four geometric metrics. Conclusions Deep learning-based OARs auto-segmentation for NPC and rectal cancer has a nonsignificant impact on most PTV and OARs dose-volume metrics. Correlations between the auto-segmentation geometric metric and dosimetric difference were not observed for most OARs.
Purpose To investigate the dosimetric impact of deep learning-based auto-segmentation of organs at risk (OARs) on nasopharyngeal and rectal cancer. Methods and materials Twenty patients, including ten nasopharyngeal carcinoma (NPC) patients and ten rectal cancer patients, who received radiotherapy in our department were enrolled in this study. Two deep learning-based auto-segmentation systems, including an in-house developed system (FD) and a commercial product (UIH), were used to generate two auto-segmented OARs sets (OAR_FD and OAR_UIH). Treatment plans based on auto-segmented OARs and following our clinical requirements were generated for each patient on each OARs sets (Plan_FD and Plan_UIH). Geometric metrics (Hausdorff distance (HD), mean distance to agreement (MDA), the Dice similarity coefficient (DICE) and the Jaccard index) were calculated for geometric evaluation. The dosimetric impact was evaluated by comparing Plan_FD and Plan_UIH to original clinically approved plans (Plan_Manual) with dose-volume metrics and 3D gamma analysis. Spearman's correlation analysis was performed to investigate the correlation between dosimetric difference and geometric metrics. Results FD and UIH could provide similar geometric performance in parotids, temporal lobes, lens, and eyes (DICE, p > 0.05). OAR_FD had better geometric performance in the optic nerves, oral cavity, larynx, and femoral heads (DICE, p < 0.05). OAR_UIH had better geometric performance in the bladder (DICE, p < 0.05). In dosimetric analysis, both Plan_FD and Plan_UIH had nonsignificant dosimetric differences compared to Plan_Manual for most PTV and OARs dose-volume metrics. The only significant dosimetric difference was the max dose of the left temporal lobe for Plan_FD vs. Plan_Manual (p = 0.05). Only one significant correlation was found between the mean dose of the femoral head and its HD index (R = 0.4, p = 0.01), there is no OARs showed strong correlation between its dosimetric difference and all of four geometric metrics. Conclusions Deep learning-based OARs auto-segmentation for NPC and rectal cancer has a nonsignificant impact on most PTV and OARs dose-volume metrics. Correlations between the auto-segmentation geometric metric and dosimetric difference were not observed for most OARs. Keywords: Treatment planning, Dosimetric, Deep learning, Auto-segmentation
Purpose To investigate the dosimetric impact of deep learning-based auto-segmentation of organs at risk (OARs) on nasopharyngeal and rectal cancer. Methods and materials Twenty patients, including ten nasopharyngeal carcinoma (NPC) patients and ten rectal cancer patients, who received radiotherapy in our department were enrolled in this study. Two deep learning-based auto-segmentation systems, including an in-house developed system (FD) and a commercial product (UIH), were used to generate two auto-segmented OARs sets (OAR_FD and OAR_UIH). Treatment plans based on auto-segmented OARs and following our clinical requirements were generated for each patient on each OARs sets (Plan_FD and Plan_UIH). Geometric metrics (Hausdorff distance (HD), mean distance to agreement (MDA), the Dice similarity coefficient (DICE) and the Jaccard index) were calculated for geometric evaluation. The dosimetric impact was evaluated by comparing Plan_FD and Plan_UIH to original clinically approved plans (Plan_Manual) with dose-volume metrics and 3D gamma analysis. Spearman’s correlation analysis was performed to investigate the correlation between dosimetric difference and geometric metrics. Results FD and UIH could provide similar geometric performance in parotids, temporal lobes, lens, and eyes (DICE, p > 0.05). OAR_FD had better geometric performance in the optic nerves, oral cavity, larynx, and femoral heads (DICE, p < 0.05). OAR_UIH had better geometric performance in the bladder (DICE, p < 0.05). In dosimetric analysis, both Plan_FD and Plan_UIH had nonsignificant dosimetric differences compared to Plan_Manual for most PTV and OARs dose-volume metrics. The only significant dosimetric difference was the max dose of the left temporal lobe for Plan_FD vs. Plan_Manual (p = 0.05). Only one significant correlation was found between the mean dose of the femoral head and its HD index (R = 0.4, p = 0.01), there is no OARs showed strong correlation between its dosimetric difference and all of four geometric metrics. Conclusions Deep learning-based OARs auto-segmentation for NPC and rectal cancer has a nonsignificant impact on most PTV and OARs dose-volume metrics. Correlations between the auto-segmentation geometric metric and dosimetric difference were not observed for most OARs.
To investigate the dosimetric impact of deep learning-based auto-segmentation of organs at risk (OARs) on nasopharyngeal and rectal cancer. Twenty patients, including ten nasopharyngeal carcinoma (NPC) patients and ten rectal cancer patients, who received radiotherapy in our department were enrolled in this study. Two deep learning-based auto-segmentation systems, including an in-house developed system (FD) and a commercial product (UIH), were used to generate two auto-segmented OARs sets (OAR_FD and OAR_UIH). Treatment plans based on auto-segmented OARs and following our clinical requirements were generated for each patient on each OARs sets (Plan_FD and Plan_UIH). Geometric metrics (Hausdorff distance (HD), mean distance to agreement (MDA), the Dice similarity coefficient (DICE) and the Jaccard index) were calculated for geometric evaluation. The dosimetric impact was evaluated by comparing Plan_FD and Plan_UIH to original clinically approved plans (Plan_Manual) with dose-volume metrics and 3D gamma analysis. Spearman's correlation analysis was performed to investigate the correlation between dosimetric difference and geometric metrics. FD and UIH could provide similar geometric performance in parotids, temporal lobes, lens, and eyes (DICE, p > 0.05). OAR_FD had better geometric performance in the optic nerves, oral cavity, larynx, and femoral heads (DICE, p < 0.05). OAR_UIH had better geometric performance in the bladder (DICE, p < 0.05). In dosimetric analysis, both Plan_FD and Plan_UIH had nonsignificant dosimetric differences compared to Plan_Manual for most PTV and OARs dose-volume metrics. The only significant dosimetric difference was the max dose of the left temporal lobe for Plan_FD vs. Plan_Manual (p = 0.05). Only one significant correlation was found between the mean dose of the femoral head and its HD index (R = 0.4, p = 0.01), there is no OARs showed strong correlation between its dosimetric difference and all of four geometric metrics. Deep learning-based OARs auto-segmentation for NPC and rectal cancer has a nonsignificant impact on most PTV and OARs dose-volume metrics. Correlations between the auto-segmentation geometric metric and dosimetric difference were not observed for most OARs.
To investigate the dosimetric impact of deep learning-based auto-segmentation of organs at risk (OARs) on nasopharyngeal and rectal cancer. Twenty patients, including ten nasopharyngeal carcinoma (NPC) patients and ten rectal cancer patients, who received radiotherapy in our department were enrolled in this study. Two deep learning-based auto-segmentation systems, including an in-house developed system (FD) and a commercial product (UIH), were used to generate two auto-segmented OARs sets (OAR_FD and OAR_UIH). Treatment plans based on auto-segmented OARs and following our clinical requirements were generated for each patient on each OARs sets (Plan_FD and Plan_UIH). Geometric metrics (Hausdorff distance (HD), mean distance to agreement (MDA), the Dice similarity coefficient (DICE) and the Jaccard index) were calculated for geometric evaluation. The dosimetric impact was evaluated by comparing Plan_FD and Plan_UIH to original clinically approved plans (Plan_Manual) with dose-volume metrics and 3D gamma analysis. Spearman's correlation analysis was performed to investigate the correlation between dosimetric difference and geometric metrics. FD and UIH could provide similar geometric performance in parotids, temporal lobes, lens, and eyes (DICE, p > 0.05). OAR_FD had better geometric performance in the optic nerves, oral cavity, larynx, and femoral heads (DICE, p < 0.05). OAR_UIH had better geometric performance in the bladder (DICE, p < 0.05). In dosimetric analysis, both Plan_FD and Plan_UIH had nonsignificant dosimetric differences compared to Plan_Manual for most PTV and OARs dose-volume metrics. The only significant dosimetric difference was the max dose of the left temporal lobe for Plan_FD vs. Plan_Manual (p = 0.05). Only one significant correlation was found between the mean dose of the femoral head and its HD index (R = 0.4, p = 0.01), there is no OARs showed strong correlation between its dosimetric difference and all of four geometric metrics. Deep learning-based OARs auto-segmentation for NPC and rectal cancer has a nonsignificant impact on most PTV and OARs dose-volume metrics. Correlations between the auto-segmentation geometric metric and dosimetric difference were not observed for most OARs.
ArticleNumber 113
Audience Academic
Author Guo, Hongbo
Zhong, Yang
Peng, Jiayuan
Wang, Jiazhou
Hu, Weigang
Zhang, Zhen
Xia, Xiang
Author_xml – sequence: 1
  givenname: Hongbo
  surname: Guo
  fullname: Guo, Hongbo
  organization: Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, China
– sequence: 2
  givenname: Jiazhou
  surname: Wang
  fullname: Wang, Jiazhou
  organization: Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, China
– sequence: 3
  givenname: Xiang
  surname: Xia
  fullname: Xia, Xiang
  organization: Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, China
– sequence: 4
  givenname: Yang
  surname: Zhong
  fullname: Zhong, Yang
  organization: Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, China
– sequence: 5
  givenname: Jiayuan
  surname: Peng
  fullname: Peng, Jiayuan
  organization: Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, China
– sequence: 6
  givenname: Zhen
  surname: Zhang
  fullname: Zhang, Zhen
  email: zhen_zhang@fudan.edu.cn, zhen_zhang@fudan.edu.cn, zhen_zhang@fudan.edu.cn
  organization: Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, China. zhen_zhang@fudan.edu.cn
– sequence: 7
  givenname: Weigang
  surname: Hu
  fullname: Hu, Weigang
  email: jackhuwg@gmail.com, jackhuwg@gmail.com
  organization: Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China. jackhuwg@gmail.com
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34162410$$D View this record in MEDLINE/PubMed
BookMark eNptUsmK3DAUNGFCZkl-IIcgyNkTbbbsS2AYsgwM5DKB3MSz9OxWx5Y6kjrQfx_19GwNQQc9SlVFPVHn1YkPHqvqPaOXjHXtp8QEZbKmnNWUdULVu1fVGVOyqxVTv05ezKfVeUprSmUjaP-mOhWStVwyelbluxUSG5JbMEdniFs2YDIJI7GIGzIjRO_8VA-Q0BLY5lAnnBb0GbILfk8McQKfCGQSXfpNCughhc0K4s5PCDMBb0lEk8towBuMb6vXI8wJ3z3cF9XPr1_urr_Xtz--3Vxf3dam5Mw1lxzAtqZtG6DWDKha1vfCNgY4o8Y2CnoGZhyGBhjroZd7nRR0gHFEC-Kiujn42gBrvYluKZl0AKfvgRJcQ8zOzKgl6xou0DQouOwU9kMjKViwI--k6k3x-nzw2myHBa0pPxBhPjI9fvFupafwV3ec046yYvDxwSCGP1tMWa_DNvqyv-ZNw1Xbyp4-syYoqZwfQzEzi0tGX7WK85aWfIV1-R9WORYXZ0pLRlfwIwE_CEwMKUUcn4Izqvdl0ocy6VImfV8mvSuiDy9XfpI8tkf8AwGqyJI
CitedBy_id crossref_primary_10_1016_j_ejmp_2024_103402
crossref_primary_10_1155_2022_4109663
crossref_primary_10_3389_fonc_2023_1213068
crossref_primary_10_1016_j_ctro_2024_100796
crossref_primary_10_1016_j_semradonc_2022_06_002
crossref_primary_10_1088_1361_6560_ace307
crossref_primary_10_1016_j_clon_2023_01_016
crossref_primary_10_1016_j_ipemt_2023_100018
crossref_primary_10_1186_s13014_022_01985_9
crossref_primary_10_1016_j_phro_2023_100454
crossref_primary_10_1016_j_ctro_2024_100769
crossref_primary_10_1016_j_phro_2024_100572
crossref_primary_10_1002_acm2_14371
crossref_primary_10_3390_jpm13060946
crossref_primary_10_3389_fonc_2022_968537
crossref_primary_10_1186_s13014_022_02121_3
crossref_primary_10_1088_1361_6560_ad2a98
Cites_doi 10.1186/s13014-020-01617-0
10.1186/s12880-015-0068-x
10.1088/1361-6560/abca05
10.1002/mp.13300
10.1016/j.radonc.2019.05.010
10.3857/roj.2019.00038
10.1088/0031-9155/60/2/R1
10.1186/s13014-020-01528-0
10.1088/1361-6560/ab25bc
10.1002/mp.14234
10.1016/j.radonc.2019.09.001
10.1002/mp.12045
10.1111/bju.14145
10.1002/acm2.12974
10.1016/j.radonc.2019.09.022
10.1061/9780784481264.003
10.1118/1.4871620
10.1002/mp.14312
10.1016/j.ijrobp.2017.09.041
10.1016/j.radonc.2020.09.045
10.1186/s13014-020-01562-y
10.1002/mp.12918
10.1002/mp.13271
10.3389/fonc.2020.616721
10.1016/j.phro.2019.11.006
10.1016/j.prro.2020.05.013
10.1016/j.semradonc.2019.02.001
10.1109/TMI.2009.2013851
10.1016/j.radonc.2018.07.013
10.1016/j.radonc.2019.10.019
ContentType Journal Article
Copyright COPYRIGHT 2021 BioMed Central Ltd.
2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2021
Copyright_xml – notice: COPYRIGHT 2021 BioMed Central Ltd.
– notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2021
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7QO
7X7
7XB
88E
8FD
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FR3
FYUFA
GHDGH
K9.
M0S
M1P
P64
PIMPY
PQEST
PQQKQ
PQUKI
5PM
DOA
DOI 10.1186/s13014-021-01837-y
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Biotechnology Research Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Technology Research Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Biotechnology and BioEngineering Abstracts
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Publicly Available Content Database
Technology Research Database
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
Biotechnology Research Abstracts
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Engineering Research Database
ProQuest One Academic
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
DatabaseTitleList
CrossRef

Publicly Available Content Database

MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1748-717X
EndPage 14
ExternalDocumentID oai_doaj_org_article_418523ec5e32487e9b540adadf28479c
A672260324
10_1186_s13014_021_01837_y
34162410
Genre Journal Article
GeographicLocations China
United States--US
GeographicLocations_xml – name: China
– name: United States--US
GroupedDBID ---
-A0
0R~
123
29P
2WC
3V.
53G
5VS
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AAWTL
ABDBF
ABUWG
ACGFS
ACRMQ
ADBBV
ADINQ
ADRAZ
ADUKV
AENEX
AFKRA
AFPKN
AHBYD
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AOIJS
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C24
C6C
CCPQU
CGR
CS3
CUY
CVF
DIK
E3Z
EBD
EBLON
EBS
ECM
EIF
ESX
F5P
FYUFA
GROUPED_DOAJ
HMCUK
HYE
I-F
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
NPM
O5R
O5S
OK1
P2P
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
TUS
UKHRP
WOQ
WOW
~8M
AAYXX
CITATION
ABVAZ
AFGXO
AFNRJ
7QO
7XB
8FD
8FK
AZQEC
DWQXO
FR3
K9.
P64
PQEST
PQUKI
5PM
ID FETCH-LOGICAL-c530t-242aad6c665a0dcbe761993d5ca210cd57a91acfbb5a119a94c530430baffeda3
IEDL.DBID RPM
ISSN 1748-717X
IngestDate Thu Sep 05 15:41:26 EDT 2024
Tue Sep 17 21:14:23 EDT 2024
Sat Aug 31 00:00:29 EDT 2024
Thu Feb 22 23:56:51 EST 2024
Fri Feb 02 04:05:30 EST 2024
Wed Sep 04 12:47:33 EDT 2024
Sat Sep 28 08:23:39 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Deep learning
Dosimetric
Auto-segmentation
Treatment planning
Language English
License Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c530t-242aad6c665a0dcbe761993d5ca210cd57a91acfbb5a119a94c530430baffeda3
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220801/
PMID 34162410
PQID 2552766490
PQPubID 55355
PageCount 14
ParticipantIDs doaj_primary_oai_doaj_org_article_418523ec5e32487e9b540adadf28479c
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8220801
proquest_journals_2552766490
gale_infotracmisc_A672260324
gale_infotracacademiconefile_A672260324
crossref_primary_10_1186_s13014_021_01837_y
pubmed_primary_34162410
PublicationCentury 2000
PublicationDate 2021-06-23
PublicationDateYYYYMMDD 2021-06-23
PublicationDate_xml – month: 06
  year: 2021
  text: 2021-06-23
  day: 23
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Radiation oncology (London, England)
PublicationTitleAlternate Radiat Oncol
PublicationYear 2021
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References J Wang (1837_CR21) 2018; 45
JL Ma (1837_CR4) 2018; 121
J van der Veen (1837_CR17) 2019; 138
CE Cardenas (1837_CR6) 2019; 29
J Fan (1837_CR23) 2019; 46
T Heimann (1837_CR28) 2009; 28
1837_CR26
1837_CR25
NP Brodin (1837_CR1) 2018; 100
I Vergalasova (1837_CR12) 2020; 47
W Chen (1837_CR16) 2020
LV van Dijk (1837_CR11) 2020; 142
B Ibragimov (1837_CR18) 2017; 44
X Xia (1837_CR22) 2020; 10
MS Choi (1837_CR14) 2020; 153
R Kaderka (1837_CR20) 2019; 131
VY Kuperman (1837_CR29) 2020; 47
W Zhu (1837_CR19) 2019; 46
J Wang (1837_CR3) 2019; 141
1837_CR15
AA Taha (1837_CR27) 2015; 15
G Sharp (1837_CR13) 2014; 41
J Wong (1837_CR7) 2020; 144
HH Barrett (1837_CR30) 2015; 60
J Fan (1837_CR24) 2020; 65
A Ayyalusamy (1837_CR8) 2019; 37
N Kim (1837_CR5) 2020; 15
S Elguindi (1837_CR9) 2019; 12
MHF Savenije (1837_CR10) 2020; 15
J Conzelmann (1837_CR31) 2020; 21
Y Liu (1837_CR2) 2019; 64
References_xml – year: 2020
  ident: 1837_CR16
  publication-title: Radiat Oncol
  doi: 10.1186/s13014-020-01617-0
  contributor:
    fullname: W Chen
– volume: 15
  start-page: 29
  year: 2015
  ident: 1837_CR27
  publication-title: BMC Med Imaging
  doi: 10.1186/s12880-015-0068-x
  contributor:
    fullname: AA Taha
– volume: 65
  start-page: 245035
  year: 2020
  ident: 1837_CR24
  publication-title: Phys Med Biol
  doi: 10.1088/1361-6560/abca05
  contributor:
    fullname: J Fan
– volume: 46
  start-page: 576
  year: 2019
  ident: 1837_CR19
  publication-title: Med Phys
  doi: 10.1002/mp.13300
  contributor:
    fullname: W Zhu
– volume: 138
  start-page: 68
  year: 2019
  ident: 1837_CR17
  publication-title: Radiother Oncol
  doi: 10.1016/j.radonc.2019.05.010
  contributor:
    fullname: J van der Veen
– volume: 37
  start-page: 134
  year: 2019
  ident: 1837_CR8
  publication-title: Radiat Oncol J
  doi: 10.3857/roj.2019.00038
  contributor:
    fullname: A Ayyalusamy
– volume: 60
  start-page: R1
  year: 2015
  ident: 1837_CR30
  publication-title: Phys Med Biol
  doi: 10.1088/0031-9155/60/2/R1
  contributor:
    fullname: HH Barrett
– volume: 15
  start-page: 104
  year: 2020
  ident: 1837_CR10
  publication-title: Radiat Oncol
  doi: 10.1186/s13014-020-01528-0
  contributor:
    fullname: MHF Savenije
– volume: 64
  start-page: 145015
  year: 2019
  ident: 1837_CR2
  publication-title: Phys Med Biol
  doi: 10.1088/1361-6560/ab25bc
  contributor:
    fullname: Y Liu
– ident: 1837_CR26
– volume: 47
  start-page: 4325
  year: 2020
  ident: 1837_CR29
  publication-title: Med Phys
  doi: 10.1002/mp.14234
  contributor:
    fullname: VY Kuperman
– volume: 141
  start-page: 67
  year: 2019
  ident: 1837_CR3
  publication-title: Radiother Oncol
  doi: 10.1016/j.radonc.2019.09.001
  contributor:
    fullname: J Wang
– volume: 44
  start-page: 547
  year: 2017
  ident: 1837_CR18
  publication-title: Med Phys
  doi: 10.1002/mp.12045
  contributor:
    fullname: B Ibragimov
– volume: 121
  start-page: 28
  year: 2018
  ident: 1837_CR4
  publication-title: BJU Int
  doi: 10.1111/bju.14145
  contributor:
    fullname: JL Ma
– volume: 21
  start-page: 201
  year: 2020
  ident: 1837_CR31
  publication-title: J Appl Clin Med Phys
  doi: 10.1002/acm2.12974
  contributor:
    fullname: J Conzelmann
– volume: 142
  start-page: 115
  year: 2020
  ident: 1837_CR11
  publication-title: Radiother Oncol
  doi: 10.1016/j.radonc.2019.09.022
  contributor:
    fullname: LV van Dijk
– ident: 1837_CR25
  doi: 10.1061/9780784481264.003
– volume: 41
  start-page: 050902
  year: 2014
  ident: 1837_CR13
  publication-title: Med Phys
  doi: 10.1118/1.4871620
  contributor:
    fullname: G Sharp
– volume: 47
  start-page: e988
  year: 2020
  ident: 1837_CR12
  publication-title: Med Phys
  doi: 10.1002/mp.14312
  contributor:
    fullname: I Vergalasova
– volume: 100
  start-page: 391
  year: 2018
  ident: 1837_CR1
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2017.09.041
  contributor:
    fullname: NP Brodin
– volume: 153
  start-page: 139
  year: 2020
  ident: 1837_CR14
  publication-title: Radiother Oncol
  doi: 10.1016/j.radonc.2020.09.045
  contributor:
    fullname: MS Choi
– volume: 15
  start-page: 106
  year: 2020
  ident: 1837_CR5
  publication-title: Radiat Oncol
  doi: 10.1186/s13014-020-01562-y
  contributor:
    fullname: N Kim
– volume: 45
  start-page: 2560
  year: 2018
  ident: 1837_CR21
  publication-title: Med Phys
  doi: 10.1002/mp.12918
  contributor:
    fullname: J Wang
– volume: 46
  start-page: 370
  year: 2019
  ident: 1837_CR23
  publication-title: Med Phys
  doi: 10.1002/mp.13271
  contributor:
    fullname: J Fan
– volume: 10
  start-page: 616721
  year: 2020
  ident: 1837_CR22
  publication-title: Front Oncol
  doi: 10.3389/fonc.2020.616721
  contributor:
    fullname: X Xia
– volume: 12
  start-page: 80
  year: 2019
  ident: 1837_CR9
  publication-title: Phys Imaging Radiat Oncol
  doi: 10.1016/j.phro.2019.11.006
  contributor:
    fullname: S Elguindi
– ident: 1837_CR15
  doi: 10.1016/j.prro.2020.05.013
– volume: 29
  start-page: 185
  year: 2019
  ident: 1837_CR6
  publication-title: Semin Radiat Oncol
  doi: 10.1016/j.semradonc.2019.02.001
  contributor:
    fullname: CE Cardenas
– volume: 28
  start-page: 1251
  year: 2009
  ident: 1837_CR28
  publication-title: IEEE Trans Med Imaging
  doi: 10.1109/TMI.2009.2013851
  contributor:
    fullname: T Heimann
– volume: 131
  start-page: 215
  year: 2019
  ident: 1837_CR20
  publication-title: Radiother Oncol
  doi: 10.1016/j.radonc.2018.07.013
  contributor:
    fullname: R Kaderka
– volume: 144
  start-page: 152
  year: 2020
  ident: 1837_CR7
  publication-title: Radiother Oncol
  doi: 10.1016/j.radonc.2019.10.019
  contributor:
    fullname: J Wong
SSID ssj0045309
Score 2.4157212
Snippet To investigate the dosimetric impact of deep learning-based auto-segmentation of organs at risk (OARs) on nasopharyngeal and rectal cancer. Twenty patients,...
Abstract Purpose To investigate the dosimetric impact of deep learning-based auto-segmentation of organs at risk (OARs) on nasopharyngeal and rectal cancer....
Purpose To investigate the dosimetric impact of deep learning-based auto-segmentation of organs at risk (OARs) on nasopharyngeal and rectal cancer. Methods and...
To investigate the dosimetric impact of deep learning-based auto-segmentation of organs at risk (OARs) on nasopharyngeal and rectal cancer. Twenty patients,...
SourceID doaj
pubmedcentral
proquest
gale
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 113
SubjectTerms Auto-segmentation
Bladder
Cancer
Colorectal cancer
Complications and side effects
Correlation analysis
Deep Learning
Dose-response relationship (Biochemistry)
Dosimetric
Dosimetry
Eye lens
Femur
Health risk assessment
Humans
Image Processing, Computer-Assisted - methods
Larynx
Machine learning
Metric space
Nasopharyngeal cancer
Nasopharyngeal carcinoma
Nasopharyngeal Neoplasms - diagnostic imaging
Nasopharyngeal Neoplasms - pathology
Nasopharyngeal Neoplasms - radiotherapy
Nerves
Optimization
Oral cavity
Organs
Organs at Risk - radiation effects
Patients
Planning
Prognosis
Radiation therapy
Radiotherapy Dosage
Radiotherapy Planning, Computer-Assisted - methods
Radiotherapy, Intensity-Modulated - methods
Rectal Neoplasms - diagnostic imaging
Rectal Neoplasms - pathology
Rectal Neoplasms - radiotherapy
Rectum
Segmentation
Technology application
Temporal lobe
Testing
Tomography, X-Ray Computed - methods
Treatment planning
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV29T9wwFLcqhqpLVShtr0DloRJDZZHYjhOPgIpQJToVic168cfBQA5dwnD_fd9zcugihi7dotiRbL-v34vt32Pse9GWwXjpRWpSErqJaFJeaYHo2STMOGTMZDo3v831rf51V93tlPqiM2EjPfC4cGdEriJV9FXE0N_U0baIMSBASORYrc_et6y2ydTog3WlCru9ItOYs76kzEHQcYQCdbgWm1kYymz9r33yTlCaH5jciUBXH9j7CTry83HI--xN7A7Y25tpc_wjG1DkPKz6h0eqkuX5eAGSrxIPMT7xqT7EUlDgChyeh5Xo4_JxunzUUcdc46nnMHA6cs7xZQdU5wDWm26JkJJDFzj5SHz0pC_rQ3Z79fPP5bWYiioIj4sy0BYwAIrHmAqK4NtI_zGsCpUHzP58qGqwJfjUthWUpQWr6TutihZSigHUJ7bXrbr4hXETSkQfykQZa-0DNMReqo2x0CrpZbFgP7Zr7J5G7gyXc47GuFEiDiXiskTcZsEuSAwvPYn3Or_AqbtJG9y_tGHBTkmIjqwTJeVhumSAAyaeK3duasSbBX68YMeznmhVft68VQM3WXXvJNHVGaMtTu3zqBEvw0U0YBANYUs905XZfOYt3cN95vNGjIa4vfz6PxbgiL2TWc2NkOqY7Q3r53iCsGlov2UL-QtC6BVL
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELZKkRAXxJtAQT4gcUDWJk7iJCdUENUKqZyotDdr4sfSQ5PtJj3sv2fGcZZGSNyi2FHizDeeb2zPDGMf0zazykgjfO29KGqHKmXyQiB7Vh49DulCMp3Ln2p9VfzYlJsTtp5jYehY5Twnhona9obWyFeSUoUpVTTpClpaBTDj6svuVlD9KNpnjcU0HrCHmURagciuNkfXqyjztJlDZmq1GjLyJAQdT0gR05U4LMxSyN7_7xx9z0gtD1Des0gXT9mTSCX5-ST7Z-zEdc_Zo8u4Wf6CjQgBbvvh-oaqZhk-BUTy3nPr3I7HehFbQYbMcrgbezG47U0MRuqoY6j5NHAYOR1B53izA6p7APtDt0WKyaGznOZMvDSEn_1LdnXx_de3tYhFFoTBnzLSljAAikupElJrWkfrGk1uSwPoDRpbVtBkYHzblpBlDTQFPVfkaQveOwv5K3ba9Z17w7iyGbKRXDnpqsJYqCmbaaFUA20ujUwT9nn-x3o35dLQwQeplZ4kolEiOkhEHxL2lcRw7El5sMMNHLqOaqUp9Y7MnSkdEsO6ck2LDBQsWE9mtzEJ-0RC1KSthBmIQQf4wZT3Sp-rCvlnig8n7GzRE7XMLJtnGOio5YP-i8mEvZ4QcfxcZAcK2RG2VAusLMazbOmuf4f83sjZkMdnb___ynfssQwAVkLmZ-x03N-590iQxvZDwP4fHFUQwQ
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1La9wwEBZpCiGX0nedpkWHQg9FrS3Jsn0oJS0NobA9dSE3MZbkbSDxpmsHuv8-M7K9xDS9GT2MpflG840lzTD2Lq0zb5x0oimbRugyoEo5pQWyZ9OgxyFDDKaz-GnOlvrHeX6-x6Z0R-MEdve6dpRParm5_Pj3z_YLKvznqPCl-dRl5BcIOmyQIkILsX3AHkqtNCF-oXe7CjpXaTVdnLm33yE7wFXdoFVLZ3YqhvP_d9G-Y7XmJyrvmKjTx-zRyC35yQCGJ2wvtE_ZwWLcPX_GesQE9-vu4orSaDk-3JDk64b7EK75mEBiJciyeQ43_Vp0YXU13k5qqWFMAtVx6DmdSedY2AIlQoDNtl0h5-TQek6LKD46AtTmOVuefv_17UyMWReEw_npaY8YAOVnTA6pd3WgHx2V8rkDdA-dzwuoMnBNXeeQZRVUmvppldbQNMGDesH223UbXjFufIb0RJkgQ6Gdh5LCm2pjKqiVdDJN2Idpju31EFzDRqekNHYQjkXh2Cgcu03YVxLDriUFxo4FOHQ76pmlWDxSBZcHZIplEaoaKSl48A3Z4col7D0J0RKgUFIOxlsI-MEUCMuemAIJaYqdE3Y8a4lq5-bVEwzshForKZ6dMbrCob0cELH73AlYCStmWJmNZ17TXvyOAb-RxCGxz47--87X7FBGGBsh1THb7zc34Q2Spb5-GzXgFqKlECo
  priority: 102
  providerName: Scholars Portal
Title The dosimetric impact of deep learning-based auto-segmentation of organs at risk on nasopharyngeal and rectal cancer
URI https://www.ncbi.nlm.nih.gov/pubmed/34162410
https://www.proquest.com/docview/2552766490/abstract/
https://pubmed.ncbi.nlm.nih.gov/PMC8220801
https://doaj.org/article/418523ec5e32487e9b540adadf28479c
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swED_aDkpfxr7nrQt6GOxhuLEtWbYf09JSAillWyFvQpbkLLA4IXYf8t_vTrZLzd72YhtbAsn3O92ddB8AX6MyttIkJqzyqgpF7pClDBchas-yQosjcT6ZzuJO3j6I-TJdHkE6xMJ4p31Tri_qP5uLev3b-1buNmY6-IlN7xdXKNRQ0Ymnx3CccT6Y6N3yK1IeFUN0TC6nTUxGQ0ieCBHCNwsPZ3CKS7dE0RWNhJHP2f_vyvxMNI3dJp_JoZtX8LJXINmsG-hrOHL1Gzhd9Efkb6FFwjO7bdYbqpVlWBcGybYVs87tWF8lYhWS-LJMP7bbsHGrTR-CVFNDX-mpYbpl5HjO8GWtqdqB3h_qFSqWTNeW0UqJj4ZQs38HDzfXv65uw760Qmjw_7R0EKw1EknKVEfWlI52MwpuU6PRBjQ2zXQRa1OVZarjuNCFoH6CR6WuKmc1fw8n9bZ2H4FJG6MOwqVLXCaM1TnlMBVSFrrkiUmiAL4P_1jtugwaylseuVQdcRQSR3niqEMAl0SGp5aU_dq_wKmrHgOKEu4k3JnUoTqYZ64oUe_UVtuKhG1hAvhGRFTEo0gpo_tQAxwwZbtSM5mh1hlh5wDORy2Rt8z48wAD1fN2oxJKWielKHBqHzpEPA13AFYA2Qgro_mMvyDIfVbvHtSf_rvnZzhLPMxlmPBzOGn3j-4LakxtOUE-WWYTeDGbzX_O8X55fXf_Y-L3H_C6EPnE89BfdYobsw
link.rule.ids 230,315,733,786,790,870,891,2115,12083,21416,24346,27957,27958,31754,33779,43345,43840,53827,53829
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELZgKwEXxJuFAj4gcUBWk9hxkhNqUasFuiuEWqk3a2I72x6aLJv0sP-emcQpjZC4RbGjxPnm8Y0fM4x9jMrYaZtYUeVVJVTuUaWsVALZs64w4kh8n0xnudKLc_X9Ir0IE25t2FY52sTeULvG0hz5QUKpwrRWRfRl81tQ1ShaXQ0lNO6zPSUxVJmxvaPj1c9foy1WqYyK8ahMrg_amCIIQdsSIpTlTOwm7qjP2v-vbb7jnKYbJ-94opMn7HGgkPxwwPwpu-frZ-zBMiySP2cdQs9d015dU7Usy4eDkLypuPN-w0OdiLUgB-Y43HSNaP36OhxCqqljX-up5dBx2nrO8WYNVO8Atrt6jdSSQ-042Uq8tCQ32xfs_OT47OtChOIKwuJP6WgpGABh0jqFyNnS03xGIV1qAaNA69IMihhsVZYpxHEBhaLnlIxKqCrvQL5ks7qp_WvGtYuRhUjtE58p6yCnLKZK6wJKmdgkmrPP4z82myGHhuljj1ybARGDiJgeEbObsyOC4bYn5b_ub-DQTVAnQyl3Eult6pEQ5pkvSmSe4MBV5G4LO2efCERDWopIWQiHDfCDKd-VOdQZ8s4IH56z_UlP1C47bR7FwATtbs1fWZyzV4NE3H4usgKNrAhbsomsTMYzbamvLvu83sjVkL_Hb_7_yg_s4eJseWpOv61-vGWPkl6YtUjkPpt12xv_DklSV74PmvAHrbERWg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF5BkaJeKM9iKLAHJA7Iib22195jKUTlkaoHKlVcVvtyiCBOFDuH9Nczs7arGG69Rfau5PF884pnvyHkXaRjyw0zYVmUZZgWDkzKJGkI2TMvoeJgzpPpzC74-VX69Tq73hv15Zv2jV6Mqz_LcbX45Xsr10sz6fvEJpezMwhqkOjEk7UtJ_fJA7BZJvpCvXXCaZZEoj8jU_BJHWPpEGI_QgQgzsPdIRmBA-cQwKJBSPLM_f_7570ANWye3ItG0yPys5ejbUL5Pd42emxu_qF4vJOgj8jDLkelp-2Sx-Seq56Q0az7Cv-UNIAtalf1YonjuAxtT1rSVUmtc2vaDaKYhxghLVXbZhXWbr7sTjlVuNAPk6qpaij2tlO4WCkcqKA2u2oOuStVlaXojOGnQWBunpGr6ecfZ-dhN70hNPDyG_zWrBTggPNMRdZoh3-YiMRmRkGZaWyWKxErU2qdqTgWSqS4L00ircrSWZU8JwfVqnIvCOU2hjQn4Y65PDVWFUiTmnIulE6YYVFAPvQKlOuWpEP64qbgstW8BM1Lr3m5C8hH1PHtSiTY9hdAdNm9fYmcPixxJnOQcRa5ExpSW2WVLTGeCxOQ94gQiW4AYGBUd5oBHhgJteQpzyGxjWBzQE4GK8F8zfB2jzHZuY9aMuTF4zwVINpxC7fbx-1RG5B8AMSBPMM7AC9PHN7B6eWdd74lo8tPU_n9y8W3V-SQeXPiIUtOyEGz2brXkJ81-o23xL_lmjpE
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+dosimetric+impact+of+deep+learning-based+auto-segmentation+of+organs+at+risk+on+nasopharyngeal+and+rectal+cancer&rft.jtitle=Radiation+oncology+%28London%2C+England%29&rft.au=Guo%2C+Hongbo&rft.au=Wang%2C+Jiazhou&rft.au=Xia%2C+Xiang&rft.au=Zhong%2C+Yang&rft.date=2021-06-23&rft.eissn=1748-717X&rft.volume=16&rft.issue=1&rft.spage=113&rft_id=info:doi/10.1186%2Fs13014-021-01837-y&rft_id=info%3Apmid%2F34162410&rft.externalDocID=34162410
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1748-717X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1748-717X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1748-717X&client=summon